载脂蛋白E介导的铁死亡调控慢性淋巴细胞白血病细胞增殖
研究发现慢性淋巴细胞白血病(CLL)细胞对血清载脂蛋白E(ApoE)的抑制敏感,生理浓度ApoE影响CLL细胞活力并抑制CD40驱动的增殖,转录组显示氧化还原和金属失衡,机制涉及ApoE诱导脂质过氧化和铁死亡,且ApoE为铜结合蛋白,细胞内铜调节其毒性;高白细胞计数患者CLL细胞对ApoE抑制敏感性较低,Richter综合征转化细胞可能抵抗ApoE,但均保持对药物诱导铁死亡的敏感性。
要点
- 生理浓度ApoE影响CLL细胞活力并抑制CD40驱动的增殖
- ApoE处理CLL细胞诱导脂质过氧化和铁死亡,且ApoE为铜结合蛋白,细胞内铜调节其毒性
- 高白细胞计数患者CLL细胞对ApoE抑制敏感性较低,Richter综合征细胞可能抵抗ApoE,但均对药物诱导铁死亡敏感
核心结论
- 研究提示存在自然抑制轴,通过铁死亡破坏CLL细胞增殖,为选择铁死亡作为CLL和Richter综合征治疗靶点提供依据。
研究设计与样本
- 研究为实验性研究,使用CLL细胞探讨ApoE的抑制作用及机制。
主要发现
- 生理浓度ApoE影响CLL细胞活力并抑制CD40驱动增殖。
- ApoE处理CLL细胞的转录组显示氧化还原和金属失衡特征。
- ApoE处理CLL细胞诱导脂质过氧化和铁死亡。
- ApoE为铜结合蛋白,细胞内铜调节ApoE毒性。
- 高白细胞计数患者CLL细胞对ApoE抑制敏感性较低,Richter综合征转化细胞可能抵抗ApoE,但两者均保持对药物诱导铁死亡的敏感性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Unraveling vulnerabilities in chronic lymphocytic leukemia (CLL) represents a key approach to understand molecular basis for its indolence and a path toward developing tailored therapeutic approaches. In this study, we found that CLL cells are particularly sensitive to the inhibitory action of abundant serum protein, apolipoprotein E (ApoE). Physiological concentrations of ApoE affect CLL cell viability and inhibit CD40-driven proliferation. Transcriptomics of ApoE-treated CLL cells revealed a signature of redox and metal disbalance which prompted us to explore the underlying mechanism of cell death. We discover, on one hand, that ApoE treatment of CLL cells induces lipid peroxidation and ferroptosis. On the other hand, we find that ApoE is a copper-binding protein and that intracellular copper regulates ApoE toxicity. ApoE regulation tends to be lost in aggressive CLL. CLL cells from patients with high leukocyte counts are less sensitive to ApoE inhibition, while resistance to ApoE is possible in transformed CLL cells from patients with Richter syndrome (RS). Nevertheless, both aggressive CLL and RS cells maintain sensitivity to drug-induced ferroptosis. Our findings suggest a natural suppression axis that mediates ferroptotic disruption of CLL cell proliferation, building up the rationale for choosing ferroptosis as a therapeutic target in CLL and RS.
引用
- Nardi F, Del Prete R, Drago R, et al. Apoliprotein E-mediated ferroptosis controls cellular proliferation in chronic lymphocytic leukemia. Leukemia. 2024. PMID: 39443737. doi:10.1038/s41375-024-02442-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。